uclagrades.com

MIMG 170: Cell and Gene Therapy

State-of-art study of stem cells and gene therapy, and approaches to treat congenital/genetic defects, diseases, or injuries in humans. Review of current knowledge of human stem cells and viral and non-viral gene delivery strategies, and how they can be safely evaluated in animal models of disease. Introduction to ethical and legal issues related to cell and gene therapy as well as how to translate therapies into practice including aspects of cell and gene therapy intellectual property, regulatory, and Food and Drug Administration considerations. Includes innovative mock company team pitches to venture capitalists to learn how to raise capital for their new inventions based on what they have learned.

4 units, lecture, discussion

Loading...

APRIL DAWN PYLESpring 20264998.0% (48)

A-range % and grade counts cover only each instructor’s latest recorded term, shown in the "Latest Data From" column, combining all sections for the course. A-range % is the share of recorded letter grades (A+ through F) that are A+, A, or A−. Parentheses show the A-range count over the total letter-grade count. P/NP and incompletes are excluded. Records may be incomplete.

Available Academic Terms
Spring 2022 · Spring 2023 · Spring 2024 · Spring 2025 · Spring 2026

This website is not affiliated with UCLA. Grade distribution data from 2021–2022 was sourced through a February 2023 public records request made under the California Public Records Act. 40+ UCLA students paid $131.25 to obtain these records. Grade distribution data from 2022–2023 and 2024–2025 were sourced similarly.

UCLA students can download the data on Google Drive (log into your UCLA Google Account to access): Fall 2021–Summer 2022, Fall 2022–Spring 2023, Summer 2023–Spring 2024, Summer 2024–Spring 2025, Summer 2025–Fall 2025, Winter 2026–Spring 2026

Source code for this site is on GitHub; contributions are welcome and appreciated. Questions, comments, bug reports, and feature requests are welcome at this link.